Location: Home
  • search
  • go
  • Relate News
  • 10/11/2021Kintor Wins Chinese Approval for Clinical Trial of ALK-1/Nivolumab Com...
  • 10/11/2021TRACON and Eucure Enter Partnership to Develop Clinical-stage CTLA-4 A...
  • 10/11/2021Brii Biosciences Files Application for EUA for BRII-196/BRII-198 Thera...
  • 10/11/2021Impact of Recent China Data Protection Laws on Asian Life Sciences Ind...
  • 10/11/2021Asia Life Sciences - Navigating US-China Relations
  • 10/11/2021Impact of the 2020 China Diabetes Society Guideline on the Prevalence ...
  • 10/9/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (50...
  • 10/9/2021Recent Executive Moves
  • 10/8/2021CDE Solicits Public Comments on the Technical Guidance on Clinical Pro...
  • 10/6/2021Zai Lab Mulls China Filing for MacroGenics' HER2 Anticancer Margetuxim...
  • 10/6/2021Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer T...
  • 10/6/2021Nature: China's Data-driven Dream to Overhaul Healthcare
  • 10/5/2021NH Reports MAT 06/2021 Data on the Chinese Cough, Cold and Allergy Mar...
  • 10/5/2021Recent Developments with A New Round of NEDL Revision
  • 10/4/2021China to Adopt Patient Reported Outcome Technology to Supplement Clini...
  • 10/4/2021LianBio Files for IPO, Plans to Apply for Nasdaq Listing
  • 10/4/2021Kintor Pharma Announces First Patient Dosing in Phase III Trial of Pro...
  • 9/30/2021NMPA Applies for Pre-accession to PIC/S    
  • 9/30/2021NMPA Issues the Announcement on eCTD Implementation
  • 9/30/2021Financial-related Company News in Brief
  • 9/30/2021Recent Executive Moves
  • 9/30/2021Luye Pharma Granted Chinese IND Approval for Class 1 New Drug LY03015
  • 9/30/2021CBMG Holdings Completes $120 Million in Series A Funding
  • 9/30/2021Biden Admin Urged by Congressional Members to Blacklist BGI and Select...
  • 9/30/2021China Upholds Healthcare Cost Containment as It Seeks to Enhance Acces...
  • 9/29/2021IQVIA: Chinese Retail Pharmacy Sales Up 0.9% in Q2/2021
  • 9/29/2021PhIIC: Chinese Hospital Drugs Sales Jumps 17.9% in H1 after Decline La...
  • 9/29/2021SMEI: Chinese Hospital Chemical Drug Sales Rebounded 17.83% in H1 Led ...
  • 9/29/2021State Council Issues the 14th Five Year Plan for Universal Healthcare ...
  • 9/29/2021Bloomberg: I-Mab Eyes Biopharma Partnerships, Possible Equity Sale
  • Page:182/789 Total number of articles:23668: [First][<<] [180] [181] [182] [183] [184] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group